Randomised Trial Ketiapine Olanzapine Fast Sedation Agitated Patients Emergency Ward

PHASE4CompletedINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

January 1, 2015

Primary Completion Date

January 1, 2016

Study Completion Date

January 31, 2016

Conditions
Psychomotor AgitationPsychiatric DisorderEmergency PsychiatricTranquilizers
Interventions
DRUG

Ketamine

"study medications were packaged in identical color-coded boxes. first dosage included either 10 mg of olanzapine, or 10 mg of ketamine Dosages were chosen based on previous studies After the initial dose, no additional dosis were allowed if supplemental medication eas needed according to clinician judgment the subject will be immediately removed from the study.~All subjects will be assessed 1 hour, 2 hours, 4 hours, 6 hours and 12 hours after t he first administration of the medication."

Trial Locations (1)

1405

hospital Larcade, San Miguel

All Listed Sponsors
lead

Universidad Nacional de Rosario

OTHER

NCT03216941 - Randomised Trial Ketiapine Olanzapine Fast Sedation Agitated Patients Emergency Ward | Biotech Hunter | Biotech Hunter